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preeclampsia in Egypt.
Methods: Twenty cases with severe preeclampsia (blood pressureP 160/110 after 20th week of ges-
tation and proteinuriaP 2.5 gm/24 h urine) were matched with 20 normotensive pregnant controls
for age, and BMI. All study participants were registered to Elshatby Maternity University Hospital
within a period of 10 months. Evaluation of serum fasting FFAs, uric acid, liver transaminases
(AST, ALT) during delivery were done.
Results: The mean level of FFAs was signiﬁcantly elevated in preeclampsia cases compared to
women with normal blood pressure (2.12 ± 2.64, 0.43 ± 0.29 respectively, p= 0.003). Also, cases
with high FFAs levels had signiﬁcant increased levels of serum uric acid than control women with
normal blood pressure (6.38 ± 1.25, 5.05 ± 1.85 respectively, p= 0.006). Women with high levels
of serum FFAs had more than two folds increased risk for neonatal admission to Neonatal Inten-
sive Care Unit OR (2.4).
Conclusion: This study suggests that elevated total serum FFAs might be an associated predispos-
ing factor with preeclampsia in non-obese pregnant women.
ª 2011 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.m (N.S. El Beltagy).
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Preeclampsia (PE) is a common pregnancy disorder that is
diagnosed by new-onset gestational hypertension after the
20th week of gestation and proteinuria (BP 140/90 mm Hg
or greater at least on two occasions, six or more hours apart,
proteinuriaP 300 mg/24 h or P1+ by dipstick.1 It is respon-
sible for approximately 50,000 maternal deaths yearly world-
wide, 25% of all cases of fetal intra uterine growth
restriction (IUGR) and 15% of preterm births in developed
countries.2–4 Preeclampsia is the most common dangerous
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It is associated with an increased risk of cardiovascular disease
and type 2 diabetes in later life of the mother.6–10 There is no
known cure for preeclampsia except delivery of the placenta.
Consequently, early diagnosis of preeclampsia and close obser-
vation are imperative.
Many theories have attempted to explain why preeclampsia
arises.11 The mechanism causing preeclampsia is not totally
understood. Much attention has been focused on the actual
physiological changes of preeclampsia which may provide a
better understanding of the disease process. Poorly functioning
endothelial cells, the cells lining the inside of blood vessels,
may be responsible for the physiologic changes of preeclamp-
sia as it can become dysfunctional altering lipid peroxidation
which is the process of converting unsaturated fatty acids in
cells and tissues. Lipid peroxidation plays a role in the develop-
ment of cardiovascular disease. There is increase in the oxida-
tive stress during pre-eclampsia and as a consequence it leads
to increased creation of lipid peroxides, reactive oxygen species
and leading to endothelial injury and dysfunction. There is
some evidence that preeclampsia patients have higher amounts
of the by-products of lipid peroxidation.12,13 Free fatty acids
which also called non-esteriﬁed fatty acids (NEFAS) are fatty
acids that are not esteriﬁed to glycerol or another alcohol such
as choline or cholesterol. In blood plasma or serum, FFAs are
really not free but bound to plasma albumin. Circulating free
fatty acids (FFAs) are key regulators of glucose metabolism
and have been shown to be increased in preeclamptic patients
during and before the clinical onset of the disease.12–14 It was
hypothesized that alterations in the circulating lipids contrib-
ute in inducing endothelial dysfunction in patients with
preeclampsia.
Therefore, the aim of this study was to estimate the relation
between serum free fatty acids (FFAs) and severe preeclampsia.
Our study may be the ﬁrst to examine the relation between
serum FFAs and severe preeclampsia in Egyptian women.
2. Methods
2.1. Study design
We conducted a case control study of nulliparous non-obese
pregnant women (BMI < 30kg/m2) aged 20–30 years. Twenty
cases with severe preeclampsia (blood pressureP 160/110
after 20th week of gestation and proteinuriaP 2.5 gm/24 h
urine) were matched with 20 normotensive pregnant controls
as regard age, and BMI. Severe preeclampsia was deﬁned by
any of the following criteria after 20 weeks gestational age:
BPP 160/110 mm Hg after 20 weeks gestation on two orTable 1 Characteristics of women with severe preeclampsia and N
Characteristics Cases of severe
preeclampsia (n= 20
Maternal age (y) 26.40 ± 3.39
BMI (kg/m2) 27.09 ± 2.13
Weeks of gestation at delivery 36.05 ± 1.15
Neonatal birth weight (gm) 2500 ± 700
Data are shown as mean ± SD, BMI: body mass index, NS: not signiﬁc
a Signiﬁcant.more occasions at least 6 h apart, proteinuriaP 5 g/24 h, or
>2+ on a voided sample, renal insufﬁciency (serum creati-
nine > 1.2 mg/dl unless known to be previously elevated),
liver affection (elevated ALT and AST), neurological and
hematological disturbance (platelets < 100,000/mm3), and
microangiopathic hemolysis.15 All study participants were reg-
istered to El Shatby Maternity University Hospital between
July 2009 and April 2010.
2.2. Measures
Upon approval from the research ethics Committee all partic-
ipants signed informed consent. Blood pressures were calcu-
lated from the average of at least three blood pressure
readings (Kortokov V, seated position) using standard cuffs
for all women ﬁtted with mercury sphygmomanometer to
minimize the variations in measurement. Urine specimens were
taken from each woman during delivery in a clean container to
be checked for albumin using clicheck 10 teco urine reagent
strips.
Evaluation of serum fasting FFAs, uric acid, AST, ALT
during delivery were done for all study participants. The con-
centration of free fatty acids in the serum was measured by an
enzymatic colorimetric method using NEFA-HR(2) colorimet-
ric assay kit (Wako Chemicals GmbH, Germany).16
2.3. Data collection
Data were gathered from women who delivered in addition to
their caring obstetricians involved as well as reviewing their
medical records.
2.4. Statistical analysis
Data were analyzed using SPSS version 13. Differences be-
tween means for quantitative variables were tested by using
independent t test. Differences in numbers for qualitative vari-
ables were tested by using X2 or Fisher Exact test. Level of
signiﬁcance equal to 0.05 was used to determine statistical
signiﬁcance.
3. Results
This is a case control study of non-obese (BMI < 30kg/m2)
pregnant women aged 20–30 years. Twenty cases with severe
preeclampsia (blood pressureP 160/110 after 20th week of
gestation and proteinuriaP 2.5 gm/24 h urine) were matched
with 20 normotensive pregnant controls for age, and BMI
(Table 1). Table 1 shows a statistical signiﬁcant differenceormotensive women.
)
Normotensive
control (n= 20)
p
25.15 ± 2.60 0.098 NS
26.30 ± 2.47 0.198 NS
38.60 ± 1.19 0.001a
3500 ± 850 0.001a
ant.
Table 2 Comparison of women with severe preeclampsia and Normotensive women according to mode of delivery, intra uterine
growth retardation (IUGR), and foetal admission to NICU.
Characteristics Cases of severe
preeclampsia (n= 20) (%)
Normotensive
women (n= 20) (%)
p
Mode of delivery Caesarean 13 (65) 6 (30) 0.027
IUGR 6 (30) 0 (0) 0.02a
Admission to NICU 9 (45) 5 (25) 0.187 NS
Data are shown as mean ± SD, NS: not signiﬁcant, NICU: Neonatal Intensive Care Unit.
a Signiﬁcant.
Table 3 Comparison of women with severe preeclampsia and Normotensive women according to serum FFA, serum uric acid, and
serum transaminases (AST, ALT).
Cases of severe
preeclampsia (n= 20)
Normotensive
women (n= 20)
p
Free fatty acids (mmol/l)
Min–Max 0.32–7.5 0.02–1.2 0.003a
Mean ± SD 2.12 ± 2.46 0.43 ± 0.20
Uric acid level (mg/dl)
Min–Max 3.5–7.8 2.4–8
Mean ± SD 6.38 ± 1.25 5.05 ± 1.85 0.0062a
AST
Min–Max 12–42 10–42
Mean ± SD 32.05 ± 7.16 19.5 ± 8.70 0.001a
ALT
Min–Max 24–48 24–60
Mean ± SD 34.75 ± 6.80 33 ± 9.75 0.275
Data are shown as mean ± SD.
a Signiﬁcant.
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regarding the gestational age at delivery (p= 0.001). Also,
we found that pre eclampsia cases had signiﬁcant lower birth
weight infants than the control (p= 0.001) (Table 1).
Caesarean section rate was signiﬁcantly higher among pre-
eclampsia women (65% versus 30%; p= 0.03) (Table 2). The
mean gestational age for vaginal delivery was 37 ± 0.15 weeks
and for the Caesarean section 36 ± 0.15 weeks. The crucial
point in deciding between vaginal delivery and CS was the suc-
cess in the control of the manifestations of severe PE within
24 h period and the presence of obstetric indication of CS as
primi breech or fetal distress.
There were six cases of severe preeclampsia had babies with
symmetrical IUGR compared to none of the normotensive
controls (Table 2). Women with preeclampsia had more than
two folds increased risk for neonatal admission to Neonatal
Intensive Care Unit OR (2.4), 95% (CI) 0.64–9.39, p= 0.2
(Table 2).
Table 3 shows the comparison between the two studied
groups as regards the total serum FFAs in mmol/litre. The ser-
um levels of FFAs in women with severe preeclampsia ranged
between 0.32 and 7.5 mmol/litre with a mean of 2.12 ±
2.64 mmol/litre. But, among normotensive control women,
plasma FFAs ranged between 0.02 and 1.2 mmol/litre with a
mean of 0.43 ± 0.29 mmol/litre. The mean level of FFAs
was signiﬁcantly elevated in preeclampsia cases compared to
control women with normal blood pressure (p= 0.003). More-over, cases with high serum FFAs levels (preeclampsia cases)
had signiﬁcant increased levels of serum uric acid than
pregnant women with normal blood pressure (6.38 ± 1.25,
5.05 ± 1.85 respectively, p= 0.006). Serum AST was signiﬁ-
cantly higher in the preeclamptic patients compared to normo-
tensive pregnant women (Table 3). On the contrary, there was
no statistical signiﬁcant difference between the two groups as
regard serum haemoglobin and serum levels of ALT (Table 3).
4. Discussion
The present study was planned to assess the relation between
serum total FFAs concentrations and severe preeclampsia in
a case control study. We found that non-obese women with
severe preeclampsia had signiﬁcant higher levels of total serum
FFAs when compared to normotensive pregnant women.
Although our study may be the ﬁrst to examine the relation
between serum FFAs and severe preeclampsia in Egyptian
women, our results were similar to other studies that have
shown high levels of serum FFAs in cases with preeclampsia
compared with normal pregnancy.17,18
Nicola et al. found that plasma from women with pre-
eclampsia had increased lipid accumulation and endothelial
apoptosis compared with plasma from women with uncompli-
cated pregnancies. They provide evidence that these changes
potentially result from elevated concentrations of free fatty
acids and increased its molar ratio to albumin. Also, they
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signiﬁcant impact on endothelial cellular metabolism and
apoptosis compared with normal pregnant controls. They con-
ﬁrmed that exposure of endothelial cells to the ‘preeclampsia’
fatty acid/albumin combination, in comparison to the ‘normal
pregnant’ cocktail of fatty acids and albumin, mimicked these
impaired outcomes, which justify suggesting that circulatory
levels of fatty acids in women with preeclampsia may be capa-
ble of affecting the properties of vascular endothelial cells.17
Similarly, Villa et al. found that total FFA and individual
FFAs (arachidonic, linoleic, oleic and palmitic acids) were
considerably higher in women with preeclampsia than in nor-
motensive pregnant women; he also found no relationship
between total FFA concentration and insulin sensitivity.18
This was so in spite of the fact that preeclampsia is character-
ized by increased insulin resistance and increased adrenergic
activity which was associated with increased lipolytic activity,
which could underlie the increased circulating levels of FFA in
pre-eclamptic women.18–20 It is unknown which single FFA is
attributed to the cause of preeclampsia but assessment of total
serum FFAs in this study may serve as a proxy measure for the
disturbed metabolism seen in preeclamptic women. Thus, in
cases with severe preeclampsia the increased levels of serum
FFAs may represent a predisposing factor. Subsequently, the
high levels of FFAs can be attributed to several mechanisms:
for example dietary intake may be suggested because pre-
eclampsia occurs more in people with low socioeconomic class
who have bad dietary habits. Meanwhile, a little is known
about Egyptian dietary habits. Additionally, future studies
are needed to understand whether or not women with severe
preeclampsia have disturbed gastrointestinal absorption of
fatty acids.
In our study we found that six women of preeclamptic
group had babies with IUGR equal 30% of cases, meanwhile
no one of the controls had babies with IUGR. Our study re-
sults were similar to studies done by Alvino et al. and Cetin
et al. have studied total plasma fatty acid concentrations in
maternal and fetal plasma in pregnancies complicated by intra-
uterine growth restriction (IUGR) and in pregnancies with
both IUGR and preeclampsia.1,21 Alvino reported total free
fatty acid concentrations signiﬁcantly higher in pregnancies
with IUGR and IUGR accompanied with preeclampsia com-
pared to controls.
Furthermore, we found that the mean serum uric acid val-
ues were signiﬁcantly elevated in preeclampsia (6.38 ± 1.25
mg/dl) compared with normal pregnancy (5.05 ± 1.85 mg/dl)
p< 0.05. Similarly, Tsukimori et al. (2008) found that the
mean serum uric acid values were signiﬁcantly elevated in
preeclampsia (6.6 ± 1.5 mg/dl) compared with normal preg-
nancy (4.0 ± 0.7 mg/dl) (p< 0.001).22 Also, we found that
AST level was higher in preeclamptic women than in women
with normal pregnancy.
This study suggests that elevated total serum FFAs might
be a predisposing factor for preeclampsia in non-obese preg-
nant women (a known risk factor for cardiovascular diseases).
Subsequently, this study might be used in future studies to pre-
vent excessive cellular non-esteriﬁed fatty Acids to reduce the
development or progression of preeclampsia.
One limitation of this study was the lack of evaluation of
individual FFAs including arachidonic acid that can be a di-
rect trigger to the occurrence of preeclampsia. Second, the
study might need to be done on overweight women and furtherstudies of detailed Egyptian dietary intake needs to be done.
Also, the obtained data should be conﬁrmed by further study
on a large scale of patients. Finally, the speciﬁc study popula-
tion may not represent women with more culture diverse
population.References
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